MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms

Claudia Goettsch1, Joshua D Hutcheson, Elena Aikawa

  • 1Harvard Medical School, Cardiovascular Medicine, Brigham and Women's Hospital, 77 Avenue Louis Pasteur, NRB-741, Boston, MA 02115, USA. eaikawa@partners.org

Circulation Research
|March 30, 2013
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in cardiovascular calcification, a process linked to chronic inflammatory diseases. Identifying common miRNAs across these conditions may offer diagnostic biomarkers and therapeutic targets for vascular calcification.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Biomarkers

Background:

  • Cardiovascular calcification is a hallmark of chronic inflammatory diseases like chronic kidney disease, type 2 diabetes mellitus, and atherosclerosis, contributing to significant morbidity and mortality.
  • While shared pathways between bone remodeling and vascular calcification are recognized, the exact mechanisms remain unclear.
  • MicroRNAs (miRNAs) are established regulators in cardiovascular and bone biology, presenting potential therapeutic avenues, yet their role in cardiovascular calcification is under-explored.

Purpose of the Study:

  • This review synthesizes current knowledge on the role of miRNAs in cardiovascular calcification, focusing on their involvement in osteogenic processes.
  • It aims to identify common miRNAs across diseases associated with cardiovascular calcification, proposing them as potential molecular signatures.
  • The review seeks to provide a framework for future research into miRNA biology for developing novel therapeutic strategies.

Main Methods:

  • Literature review focusing on microRNA (miRNA) involvement in cardiovascular disease and bone biology.
  • Analysis of existing data to identify miRNAs common to chronic kidney disease, type 2 diabetes mellitus, and atherosclerosis.
  • Discussion of osteogenic processes, including osteogenic differentiation and matrix vesicle release, in the context of miRNA regulation.

Main Results:

  • MicroRNAs play a critical regulatory role in cardiovascular and bone biology.
  • A subset of miRNAs is shared among chronic kidney disease, type 2 diabetes mellitus, and atherosclerosis.
  • These shared miRNAs may serve as a molecular signature for cardiovascular calcification.

Conclusions:

  • MicroRNAs are integral to the pathogenesis of cardiovascular calcification.
  • Identifying shared miRNAs across related chronic inflammatory diseases offers potential for novel diagnostic biomarkers and therapeutic targets.
  • Further research into miRNA biology in cardiovascular calcification is crucial for developing effective treatments.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...